No Data
United Imaging Medical (688271.SH): plans to invest 28.4872 million yuan in Asia Vets.
On December 20, Glonghui reported that United Imaging Medical (688271.SH) announced that the company is using 28.4872 million yuan of its own funds to invest in Asia Vets. The Board of Directors has authorized the management to handle matters including but not limited to contract signing and fund disbursement. In this Trade, United Imaging Group intends to acquire a 2.0000% stake in Asia Vets after the capital increase with its own funds, while Shanghai Lianhe plans to acquire a 1.7901% stake in Asia Vets after the capital increase with its own funds. Given that United Imaging Group is the controlling Shareholder of the company, and Shanghai Lianhe directly holds more than 5% of the company's shares, Asia Vets is under the control of the company's controlling Shareholder, United Imaging Group.
Is Shanghai United Imaging Healthcare Co., Ltd. (SHSE:688271) Expensive For A Reason? A Look At Its Intrinsic Value
United Imaging Medical (688271.SH): has mastered the core technology of the integrated Computed Tomography guided linear accelerator system.
On December 16, Gelonghui reported that United Imaging (688271.SH) stated on the investor interaction platform that in the field of radiotherapy, the company has mastered the core technology of the integrated Computed Tomography guided linear accelerator system and has achieved independent research and development and production of major core components.
United Imaging Medical (688271.SH): In the field of MRI, AI applications are mainly reflected in imaging acceleration, lesion detection, and examination process optimization.
Gelonghui reported on December 16 that United Imaging Medical (688271.SH) stated on an interactive platform that as AI in Medical imaging is thriving globally, pioneering technologies such as deep learning, full digitization, and Metaverse integration are being combined with Medical imaging diagnostic equipment, thus accelerating the speed of image information processing and improving the accuracy of information processing. In the MR field, AI applications mainly manifest in imaging acceleration, lesion detection, and optimization of examination processes. The company's rapid imaging technology for magnetic resonance equipment is industry-leading, and the MR equipped with the uAIFI technology platform can achieve rapid dynamic high-definition imaging at 0.5 seconds per phase.
Zhaoyuan International: Health insurance continues to support innovation, and the fund's revenue and expenditure are expected to improve.
The updated policies for medical devices are expected to be implemented quickly, promoting the recovery of profits for domestic medical device companies.
United Imaging Medical (688271.SH): The "marketing services network project" is proposed to be finalized and the remaining raised funds will be permanently supplemented with working capital.
On November 28, GeLongHui announced that Lianying Medical (688271.SH) disclosed that the investment project to be completed this time is the “marketing services network project”, the project has reached the planned available state, and meets the completion requirements. During the implementation of the fundraising project, certain deposit interest income was generated during the fundraising period. As of November 21, 2024, the balance of funds in the “marketing services network project” fundraising special account is 33.0484 million yuan. In order to improve the efficiency of the use of fundraising funds, the company plans to combine the surplus fundraising funds totaling 33.0484 million yuan (including bank deposit interest).
102884128 : getting disappointed with this counter. every day drop.